Molecular Interaction Characterization Strategies for the Development of New Biotherapeutic Antibody Modalities.
Ontology highlight
ABSTRACT: The characterization of target binding interactions is critical at each stage of antibody therapeutic development. During early development, it is important to design fit-for-purpose in vitro molecular interaction characterization (MIC) assays that accurately determine the binding kinetics and the affinity of therapeutic antibodies for their targets. Such information enables PK/PD (pharmacokinetics/pharmacodynamics) modeling, estimation of dosing regimens, and assessment of potency. While binding kinetics and affinities seem to be readily obtained, there is little discussion in the literature on how the information should be generated and used in a systematic manner along with other approaches to enable key drug development decisions. The introduction of new antibody modalities poses uniqu
SUBMITTER: Wang X
PROVIDER: S-EPMC7344756 | biostudies-literature | 2020 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA